Literature DB >> 15900076

theta Isoform of protein kinase C alters barrier function in intestinal epithelium through modulation of distinct claudin isotypes: a novel mechanism for regulation of permeability.

A Banan1, L J Zhang, M Shaikh, J Z Fields, S Choudhary, C B Forsyth, A Farhadi, A Keshavarzian.   

Abstract

Using monolayers of intestinal Caco-2 cells, we discovered that the isoform of protein kinase C (PKC), a member of the "novel" subfamily of PKC isoforms, is required for monolayer barrier function. However, the mechanisms underlying this novel effect remain largely unknown. Here, we sought to determine whether the mechanism by which PKC- disrupts monolayer permeability and dynamics in intestinal epithelium involves PKC--induced alterations in claudin isotypes. We used cell clones that we recently developed, clones that were transfected with varying levels of plasmid to either stably suppress endogenous PKC- activity (antisense, dominant-negative constructs) or to ectopically express PKC- activity (sense constructs). We then determined barrier function, claudin isotype integrity, PKC- subcellular activity, claudin isotype subcellular pools, and claudin phosphorylation. Antisense transfection to underexpress the PKC- led to monolayer instability as shown by reduced 1) endogenous PKC- activity, 2) claudin isotypes in the membrane and cytoskeletal pools ( downward arrowclaud-1, downward arrowclaud-4 assembly), 3) claudin isotype phosphorylation ( downward arrow phospho-serine, downward arrow phospho-threonine), 4) architectural stability of the claudin-1 and claudin-4 rings, and 5) monolayer barrier function. In these antisense clones, PKC- activity was also substantially reduced in the membrane and cytoskeletal cell fractions. In wild-type (WT) cells, PKC- (82 kDa) was both constitutively active and coassociated with claudin-1 (22 kDa) and claudin-4 (25 kDa), forming endogenous PKC-/claudin complexes. In a second series of studies, dominant-negative inhibition of the endogenous PKC- caused similar destabilizing effects on monolayer barrier dynamics, including claudin-1 and -4 hypophosphorylation, disassembly, and architectural instability as well as monolayer disruption. In a third series of studies, sense overexpression of the PKC- caused not only a mostly cytosolic distribution of this isoform (i.e., <12% in the membrane + cytoskeletal fractions, indicating PKC- inactivity) but also led to disruption of claudin assembly and barrier function of the monolayer. The conclusions of this study are that PKC- activity is required for normal claudin assembly and the integrity of the intestinal epithelial barrier. These effects of PKC- are mediated at the molecular level by changes in phosphorylation, membrane assembly, and/or organization of the subunit components of two barrier function proteins: claudin-1 and claudin-4 isotypes. The ability of PKC- to alter the dynamics of permeability protein claudins is a new function not previously ascribed to the novel subfamily of PKC isoforms.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15900076     DOI: 10.1124/jpet.104.083428

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  30 in total

1.  Phosphorylation of claudin-4 by PKCepsilon regulates tight junction barrier function in ovarian cancer cells.

Authors:  Theresa D'Souza; Fred E Indig; Patrice J Morin
Journal:  Exp Cell Res       Date:  2007-07-13       Impact factor: 3.905

2.  Dysregulation of claudin-7 leads to loss of E-cadherin expression and the increased invasion of esophageal squamous cell carcinoma cells.

Authors:  Mercedes Lioni; Patricia Brafford; Claudia Andl; Anil Rustgi; Wafik El-Deiry; Meenhard Herlyn; Keiran S M Smalley
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

Review 3.  Regulation of paracellular permeability: factors and mechanisms.

Authors:  Yan-Jun Hu; Yi-Dong Wang; Fu-Qing Tan; Wan-Xi Yang
Journal:  Mol Biol Rep       Date:  2013-09-24       Impact factor: 2.316

Review 4.  Claudins: control of barrier function and regulation in response to oxidant stress.

Authors:  Christian E Overgaard; Brandy L Daugherty; Leslie A Mitchell; Michael Koval
Journal:  Antioxid Redox Signal       Date:  2011-05-09       Impact factor: 8.401

Review 5.  Protein kinases are potential targets to treat inflammatory bowel disease.

Authors:  Lei Yang; Yutao Yan
Journal:  World J Gastrointest Pharmacol Ther       Date:  2014-11-06

Review 6.  Polymeric nanoparticle drug delivery technologies for oral delivery applications.

Authors:  Eric M Pridgen; Frank Alexis; Omid C Farokhzad
Journal:  Expert Opin Drug Deliv       Date:  2015-03-26       Impact factor: 6.648

7.  Experimental obstructive jaundice alters claudin-4 expression in intestinal mucosa: effect of bombesin and neurotensin.

Authors:  Stelios F Assimakopoulos; Constantine E Vagianos; Aristides S Charonis; Ilias H Alexandris; Iris Spiliopoulou; Konstantinos C Thomopoulos; Vassiliki N Nikolopoulou; Chrisoula D Scopa
Journal:  World J Gastroenterol       Date:  2006-06-07       Impact factor: 5.742

Review 8.  Emerging multifunctional roles of Claudin tight junction proteins in bone.

Authors:  Fatima Z Alshbool; Subburaman Mohan
Journal:  Endocrinology       Date:  2014-04-23       Impact factor: 4.736

9.  Protein kinase C activation has distinct effects on the localization, phosphorylation and detergent solubility of the claudin protein family in tight and leaky epithelial cells.

Authors:  Anita Sjö; Karl-Eric Magnusson; Kajsa Holmgren Peterson
Journal:  J Membr Biol       Date:  2010-08-10       Impact factor: 1.843

10.  Protein kinase C-theta regulates KIT expression and proliferation in gastrointestinal stromal tumors.

Authors:  W-b Ou; M-j Zhu; G D Demetri; C D M Fletcher; J A Fletcher
Journal:  Oncogene       Date:  2008-06-02       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.